3rd Annual LNP Formulation and Process Development Summit

42 42 people viewed this event.

This April, the 3rd LNP Formulation and Process Development Summit returns to Boston, bringing together over 400 experts in LNP Biology, Chemistry, Formulation, Analytical Development, Process Development, Manufacturing and more. This is your ultimate platform for sharing insights, learning new concepts and networking to propel more LNPs into the clinic in 2024.

Join the ever-growing community of LNP pioneers as they tackle the challenges associated with developing safe, compliant and efficacious LNPs, to treat a variety of disease indications at a variety of target organs. This starts with the in vitro discovery of LNPs through to the manufacturing processes, with end-to-end synergy fundamental.
Hear from industry powerhouses Pfizer, Moderna, Alnylam and more, as well as new companies to share their insights to this community including Capstan Therapeutics, AbbVie, Mana Bio, Serina Therapeutics, Karma Biotechnologies and more.
With an expanded content offering and a 4-track, 4-day summit format, we continue to be the most comprehensive, premium LNP content available to industry. Part of this year’s content growth, the addition of the ‘LNP IP and Commercial Partnerships Focus Day’ has evolved with the current industry trends to secure long standing partnership to demonstrate clinical results, as well as gaining a further handle on the current IP and legal landscape.


Time: 8:00 AM – 5:00 PM

Venue details: The Westin Boston Seaport District, 425 Summer Street, Boston, Massachusetts, 02210, United States

Prices: USD 3459.00 – USD 7095.00

Speakers: Alexander Aust, Founder, LNP Consultant, Aust Business Solutions, and more

Organizer - Hanson Wade



29 Apr. 2024
01 May. 2024





Topic Area

Share With Colleagues